SureshKumarBalasubramanianMD

PubMed

• Paroxysmal nocturnal hemoglobinuria-related thrombosis in the era of novel therapies: a 2043 patient/years analysis.
  Carmelo Gurnari, Simona Pagliuca, Naomi Kawashima, Yasuo Kubota, Valeria Visconte, Bhumika J Patel, Vikram Dhillon, Hussein Awada, Danai Dima, Fauzia Ullah, Ceylan Col...> ;Blood. 2024 Mar 21
• Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia.
  Tariq Kewan, Arda Durmaz, Waled Bahaj, Carmelo Gurnari, Laila Terkawi, Hussein Awada, Olisaemeka D Ogbue, Ramsha Ahmed, Simona Pagliuca, Hassan Awada, Yasuo Kubota, Mi...> ;Nature Communications. 2024 Feb 8
• 1 citations
  The crossroads of cancer therapies and clonal hematopoiesis.
  Abhay Singh, Suresh Balasubramanian> ;Seminars in Hematology. 2024 Feb 1
• Manifestation of Pancytopenia Associated with COVID-19 as Paroxysmal Nocturnal Hemoglobinuria (PNH) and Aplastic Anemia (AA).
  Aguilar, J., Dhillon, V., Balasubramanian, S.> ;Hematology Reports. 2024 Jan 17
• Inflammation of actinic keratosis from chemotherapy in a relapsed multiple myeloma patient.
  Abdul Moiz Khan, Tarec Micho Ulbeh, Jeffrey Zonder, Suresh Balasubramanian> ;BMJ Case Reports. 2023 Nov 21
• 1 citations
  Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia.
  Waled Bahaj, Tariq Kewan, Carmelo Gurnari, Arda Durmaz, Ben Ponvilawan, Ishani Pandit, Yasuo Kubota, Olisaemeka D Ogbue, Misam Zawit, Yazan Madanat, Taha Bat, Suresh K...> ;Journal of Hematology & Oncology. 2023 Aug 3
• 2 citations
  Molecular patterns identify distinct subclasses of myeloid neoplasia.
  Tariq Kewan, Arda Durmaz, Waled Bahaj, Carmelo Gurnari, Laila Terkawi, Hussein Awada, Olisaemeka D Ogbue, Ramsha Ahmed, Simona Pagliuca, Hassan Awada, Yasuo Kubota, Mi...> ;Nature Communications. 2023 May 30
• 2 citations
  Novel Scheme for Defining the Clinical Implications of TP53 Mutations in Myeloid Neoplasia.
  Waled Bahaj, Tariq Kewan, Carmelo Gurnari, Arda Durmaz, Ben Ponvilawan, Ishani Pandit, Yasuo Kubota, Olisaemeka D Ogbue, Misam Zawit, Yazan Madanat, Taha Bat, Suresh K...> ;Research Square. 2023 Mar 9
• 1 citations
  Efficacy analysis of different FLT3 inhibitors in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndrome.
  Mahesh Swaminathan, Mai M Aly, Abdul Moiz Khan, Bayan Al Share, Vikram Dhillon, Enxhi Lalo, Harry Ramos, Katherine G Akers, Seongho Kim, Suresh Balasubramanian> ;Ejhaem. 2023 Feb 1
• Late Presentation of Dyskeratosis Congenita: Germline Predisposition to Adult-Onset Secondary Acute Myeloid Leukemia.
  Harry Ramos, Mai Mostafa Aly, Suresh Kumar Balasubramanian> ;Hematology Reports. 2022 Oct 2
• 9 citations
  Selective inhibition of nuclear export: a promising approach in the shifting treatment paradigms for hematological neoplasms.
  Suresh Kumar Balasubramanian, Asfar S Azmi, Jaroslaw Maciejewski> ;Leukemia. 2022 Mar 1
• 8 citations
  PAK4 and NAMPT as Novel Therapeutic Targets in Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma.
  Husain Yar Khan, Md Hafiz Uddin, Suresh Kumar Balasubramanian, Noor Sulaiman, Marium Iqbal, Mahmoud Chaker, Amro Aboukameel, Yiwei Li, William Senapedis, Erkan Baloglu...> ;Cancers. 2021 Dec 29
• 23 citations
  Distinct clinical and biological implications of CUX1 in myeloid neoplasms.
  Mai Aly, Zubaidah M. Ramdzan, Yasunobu Nagata, Suresh Kumar Balasubramanian, Naoko Hosono, Hideki Makishima, Valeria Visconte, Teodora Kuzmanovic, Vera Adema, Aziz Naz...> ;Blood Advances. 2019 Jul 23
• Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab.
  Badar T, Szabo A, Advani A, Wadleigh M, Arslan S, Khan MA, Aldoss I, Siebenaller C, Schultz E, Hefazi M, Shallis RM, Yurkiewicz I, Podoltsev N, Patel AA, Curran E, Bal...> ;Blood advances.
• Real-World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated With Inotuzumab Ozogamicin.
  Badar T, Szabo A, Wadleigh M, Liedtke M, Arslan S, Siebenaller C, Aldoss I, Schultz E, Hefazi M, Litzow MR, Kuo E, Wang A, Curran E, Shallis RM, Podoltsev N, Balasubra...> ;Clinical lymphoma, myeloma & leukemia. 2020-03-19
• 26 citations
  Impact of EGFR mutation and ALK rearrangement on the outcomes of non-small cell lung cancer patients with brain metastasis.
  Suresh Kumar Balasubramanian, Mayur Sharma, Vyshak Alva Venur, Philipp Schmitt, Rupesh Kotecha, Samuel T. Chao, John H. Suh, Lilyana Angelov, Alireza M. Mohammadi, Mic...> ;Neuro-Oncology. 2019 Oct 24
• 8 citations
  Therapeutic outcomes using subcutaneous low dose alemtuzumab for acquired bone marrow failure conditions.
  Swapna Thota, Bhumika J. Patel, Suresh Kumar Balasubramanian, Srinivasa R. Sanikommu, Cassandra M. Hirsch, Serena Marotta, Mikkael A. Sekeres, Antonio M. Risitano, Jar...> ;British Journal of Haematology. 2018 Oct 1
• 10 citations
  The evolution of paroxysmal nocturnal haemoglobinuria depends on intensity of immunosuppressive therapy.
  Taha Bat, Omnia N. Abdelhamid, Suresh Kumar Balasubramanian, Aly Mai, Tomas Radivoyevitch, Michael J. Clemente, Jaroslaw P. Maciejewski> ;British Journal of Haematology. 2018 Sep 1
• 16 citations
  Fanconi Anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML.
  Bartlomiej P Przychodzen, Hideki Makishima, Mikkael A. Sekeres, Suresh Kumar Balasubramanian, Swapna Thota, Bhumika J. Patel, Michael J. Clemente, Cassandra M. Hirsch,...> ;Oncotarget. 2018 Jan 5
• 10 citations
  Clinical implications of somatic mutations in aplastic anemia and myelodysplastic syndrome in genomic age
  Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian> ;Hematology. American Society of Hematology. Education Program. 2017 Dec 8
• 44 citations
  Rational management approach to pure red cell aplasia
  Suresh Kumar Balasubramanian, Swapna Thota, Mai Aly, Bartlomiej P Przychodzen, Cassandra M. Hirsch, Valeria Visconte, Tomas Radivoyevitch, Jaroslaw P. Maciejewski> ;Haematologica. 2017 Dec 7
• Distinct clinical and biological implications of various DNMT3A mutations in myeloid neoplasms.
  Balasubramanian SK, Aly M, Nagata Y, Bat T, Przychodzen BP, Hirsch CM, Adema V, Visconte V, Kuzmanovic T, Radivoyevitch T, Nazha A, Mukherjee S, Sekeres MA, Maciejewsk...> ;Leukemia. 2017-09-22
• 295 citations
  Management of Brain Metastases in Tyrosine Kinase Inhibitor–Naïve Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer: A Retrospective Multi-Institution...
  William J. Magnuson, Nataniel H. Lester-Coll, Abraham J. Wu, T. Jonathan Yang, Natalie A. Lockney, Naamit K. Gerber, Kathryn Beal, Arya Amini, Tejas Patil, Brian D. Ka...> ;Journal of Clinical Oncology. 2017 Jan 23
• 24 citations
  Longitudinal experience with WHO Grade III (anaplastic) meningiomas at a single institution
  Suresh Kumar Balasubramanian, Mayur Sharma, Danilo Silva, Vidhya Karivedu, Philipp Schmitt, Glen Stevens, Gene H. Barnett, Richard A. Prayson, Paul Elson, John H. Suh,...> ;Journal of Neuro-Oncology. 2017 Feb 1
• 62 citations
  Laser interstitial thermal therapy in the management of brain metastasis and radiation necrosis after radiosurgery: An overview
  Mayur Sharma, Suresh Kumar Balasubramanian, Danilo Silva, Gene H. Barnett, Alireza M. Mohammadi> ;Expert Review of Neurotherapeutics. 2016 Feb 8
• Join now to see all

Abstracts/Posters

• Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Inotuzumab Ozogamicin
  Suresh Kumar Balasubramanian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Blinatumomab
  Suresh Kumar Balasubramanian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019